320 related articles for article (PubMed ID: 18585835)
21. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
Peng L; Wei SY; Li LT; He YX; Li B
J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial.
Nikolopoulou A; Condon M; Turner-Stokes T; Cook HT; Duncan N; Galliford JW; Levy JB; Lightstone L; Pusey CD; Roufosse C; Cairns TD; Griffith ME
BMC Nephrol; 2019 Sep; 20(1):352. PubMed ID: 31492152
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
[TBL] [Abstract][Full Text] [Related]
26. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
Yi ZW; Wu XC; Xu H; Zhou LJ; Wu YB; Feng SP; Zhou JH; Yang Q; Zhu GH; Liu AM; Wei MJ; Yu L; Zeng ZF
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil treatment for primary glomerular diseases.
Choi MJ; Eustace JA; Gimenez LF; Atta MG; Scheel PJ; Sothinathan R; Briggs WA
Kidney Int; 2002 Mar; 61(3):1098-114. PubMed ID: 11849465
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate Mofetil with Steroid, a Reasonable Alternative to Current First-line Therapy, for Idiopathic Membranous Nephropathy in Resource-constrained Settings: A Randomized, Open-label Study.
Sharma M; Roy A; Doley PK; Pegu G
J Assoc Physicians India; 2024 Jun; 72(6):15-19. PubMed ID: 38881128
[TBL] [Abstract][Full Text] [Related]
29. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
30. Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study.
Ballarin J; Poveda R; Ara J; Pérez L; Calero F; Grinyó JM; Romero R
Nephrol Dial Transplant; 2007 Nov; 22(11):3196-201. PubMed ID: 17595183
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.
Praga M; Barrio V; Juárez GF; Luño J;
Kidney Int; 2007 May; 71(9):924-30. PubMed ID: 17377504
[TBL] [Abstract][Full Text] [Related]
32. Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children.
Trachtman H; Christen E; Frank R; Rini J; Palestro C; Perelstein E; Weiss L; Tarapore F; Fortune S; Horowitz J
Am J Kidney Dis; 2008 Oct; 52(4):706-15. PubMed ID: 18554762
[TBL] [Abstract][Full Text] [Related]
33. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115
[TBL] [Abstract][Full Text] [Related]
34. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
Frutos MA; López V; Alférez MJ; Aranda P
Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
[TBL] [Abstract][Full Text] [Related]
35. Long-term study of mycophenolate mofetil treatment in IgA nephropathy.
Tang SC; Tang AW; Wong SS; Leung JC; Ho YW; Lai KN
Kidney Int; 2010 Mar; 77(6):543-9. PubMed ID: 20032964
[TBL] [Abstract][Full Text] [Related]
36. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
[TBL] [Abstract][Full Text] [Related]
37. [Case of MMF monotherapy for membranous nephropathy].
Kobayashi M; Kojima C; Sugiura H; Aoki A; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Nihon Jinzo Gakkai Shi; 2010; 52(5):572-7. PubMed ID: 20715589
[TBL] [Abstract][Full Text] [Related]
38. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria.
Borba EF; Guedes LK; Christmann RB; Figueiredo CP; Gonçalves CR; Bonfá E
Rheumatol Int; 2006 Oct; 26(12):1078-83. PubMed ID: 16736162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
